Results 241 to 250 of about 17,743 (275)

Immunotherapy approaches for malignant pleural mesothelioma

Nature Reviews Clinical Oncology, 2022
Dean A Fennell
exaly  

Solitary peritoneal mesothelioma

The American Journal of Surgery, 1964
H W, WALLACE, W C, DAVIS
openaire   +2 more sources

Peritoneal mesothelioma.

Critical reviews in diagnostic imaging, 1985
The definitive diagnosis of peritoneal mesothelioma and its differentiation from metastatic peritoneal carcinomatosis may be difficult because of the clinical, macroscopic, and microscopic variability of the tumor. To this purpose, a combination of criteria, including the clinical picture, the gross pathologic findings, the exclusion of other primary ...
openaire   +1 more source

Peritoneal Mesothelioma.

1997
-
QUITADAMO S., ERRICHI BRUNO MARIA, MASCITELLI, Elia, CIPOLLONE, Giuseppe   +3 more
openaire   +1 more source

First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial

Lancet, The, 2021
Arnaud Scherpereel, Anna K Nowak, Nobukazu Fujimoto   +2 more
exaly  

Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial

Nature Medicine, 2021
Patrick Forde, Valsamo Anagnostou, Suzanne E Dahlberg   +2 more
exaly  

Peritoneal mesothelioma

The American Journal of Surgery, 1955
openaire   +2 more sources

Macrocystic Peritoneal Mesothelioma

Southern Medical Journal, 1985
W J, Wetzel, D K, Fulbright
openaire   +2 more sources

Malignant Peritoneal Mesothelioma

American Journal of Clinical Pathology, 1961
A, BOLIO-CICERO, J, AGUIRRE, R, PEREZ-TAMAYO   +2 more
openaire   +2 more sources

Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity

Nature Genetics, 2023
Lise Mangiante, Nicolas Alcala, Abel Gonzalez-Perez   +2 more
exaly